Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rizatriptan versus Betahistine in Vestibular Migraine Treatment
IRCT20230913059428N1Phase 3Completed
- Sponsor
- Tabriz University of Medical Sciences
- Start
- Oct 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial in vestibular migraine (VM) comparing Rizatriptan arm with Betahistine arm (2 arms). Started Oct 2023; status: completed.
02
Drugs
rizatriptanbetahistine
03
Conditions
vestibular migraine (VM)
Beyond the preview
Go deeper on IRCT20230913059428N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20230913059428N1.